CLINICAL_TRIALS
research
· 2026-04-09
Clinical Trial Update: Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer [NA]
Summary
This document is an update on a neoadjuvant dietary intervention trial for intermediate-risk prostate cancer, currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | NA | Status: ACTIVE_NOT_RECRUITING